Loading
NASDAQHealthcareMedical - Specialties
Latest quote
$11.55
−$0.23 · -1.95%
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Previous close
$11.55
−$0.23 · -1.95%
Pre-market
$11.613
+$0.063 · +0.55%
Oct 9, 4:07 AM ET
Regular session · ET · Market data may be delayed.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Day range
Current $11.55
52-week range
Current $11.55
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
53
Fair Value
Sentiment
49
Mixed
Risk
47
Elevated Risk
Momentum
55
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Day range
Current $11.55
52-week range
Current $11.55
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 56.2M USD | 59.63M USD | 50.23M USD | 46.85M USD | 42.21M USD |
| Cost of goods sold | 29.4M USD | 29.71M USD | 24.91M USD | 20.83M USD | 18.97M USD |
| Gross profit | 26.8M USD | 29.93M USD | 25.32M USD | 26.02M USD | 23.23M USD |
| Research and development | 13.8M USD | 25.5M USD | 21.9M USD | 17.53M USD | 13.07M USD |
| Selling, general, and administrative | 37.18M USD | — | — | 43.88M USD | 32.24M USD |
| Operating expenses | 50.98M USD | 106.64M USD | 68.08M USD | 61.41M USD | 45.3M USD |
| Interest income | 4.14M USD | 4.49M USD | 6.48M USD | 2.03M USD | 548K USD |
| Interest expense | — | — | 201K USD | 129K USD | 486K USD |
| Depreciation and amortization | 4.47M USD | 4.68M USD | 2.38M USD | 1.61M USD | 925K USD |
| Operating income | −24.18M USD | −76.72M USD | −42.76M USD | −35.38M USD | −22.07M USD |
| Net income | −36.64M USD | −72.21M USD | −36.4M USD | −33.56M USD | −22.17M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$12.00
3.90% upsideFunds reporting this stock among their holdings, ordered by reported position size.
ARK Genomic Revolution ETFARKG22.63M1.10%1.56B USD0.75%$49.29-1.70%
Avantis U.S. Small Cap Value ETFAVUV11.2M0.04%30.54B USD0.25%$120.13+0.84%
Vanguard Morningstar Total Stock Market ETFVTI9.81M0.00%2.3T USD0.03%$379.56-0.39%
iShares Russell 2000 ETFIWM9.66M0.01%77.7B USD0.19%$277.57-0.05%
Vanguard Extended Market ETFVXF3.63M0.00%95.4B USD0.05%$233.13-0.15%
Schwab U.S. Small-Cap ETFSCHA2.06M0.01%21.7B USD0.03%$32.66+0.15%
Vanguard Russell 2000 ETFVTWO1.78M0.01%18B USD0.06%$112.1-0.10%
iShares Micro-Cap ETFIWC1.18M0.09%1.32B USD0.60%$182.79-0.31%ARK Genomic Revolution ETFARKGAvantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
